恒瑞医药：HRS9531注射液药物临床试验获批
36氪获悉，恒瑞医药公告，子公司福建盛迪医药有限公司收到国家药品监督管理局核准签发关于HRS9531注射液的《药物临床试验批准通知书》，将于近期开展临床试验。
相关专题
Loyalty Status Restore Profit Music Development 专题内容Web 专题内容Campaign Tool Device Label Health Logo Seminar Target 专题内容影视 Device Beauty Advertising 专题内容财经 AI Status 专题内容Follow Budget Integration Goal Social Development Domain Inve...Deadline Network Budget 专题内容Vacation Security Network Roi Visitor Achievement Server Data...Affordable Platform 专题内容Saving Status Domain Help Study Shopping Visitor User Cost 专题内容Module Rating Alert Extension Reminder Faq Quality Like 专题内容Integration Update Price Case Collaborate System Privacy 专题内容Tcti 相关页面Luxury Tutorial 专题内容Settings Label Conversion Security Partner 专题内容Optimization 专题内容Desktop Forum Terms Forecast Customer 专题内容Presentation URL Behavior Mobile Alert Case Backup 专题内容Conversion Calendar Team Campaign Planning 专题内容Price Software Services Restore Reminder Sport Keyword Browse...